ANIKAnika Therapeutics, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · anika.com

21.78USD+2.45%Mkt Cap: 291.48M $P/E: —3d ago

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and ser…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap291.48M $

Enterprise Value272.43M $

Revenue (TTM)120.65M $

Gross Profit63.81M $

Net Income (TTM)-10.88M $

Revenue/Share8.687 USD

Last Price21.78 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees235

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)22.46

PEG5.53

EV/EBITDA89.61

EV/Revenue2.26

P/S2.37

P/B2.08

EPS (TTM)-0.23

EPS (Forward)0.95

52W Range

8.22092% of range22.88

52W High22.88 USD

52W Low8.220 USD

Profitability

Gross Margin56.56%

Oper. Margin11.43%

EBITDA Margin2.52%

Profit Margin-9.64%

ROE-7.58%

ROA-5.72%

Growth

Revenue Growth15.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF11.19M $

CapEx (TTM)6.83M $

FCF Margin2.54%

FCF Yield1.05%

Net Debt-13.16M $

Net Debt/EBITDA-4.33

Balance Sheet

Debt/Equity0.18

Current Ratio4.48

Quick Ratio3.05

Book Value/Sh10.26 USD

Cash/Share2.870 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)21.00 USD

Upside (mean)-3.6%

Target Range21.00 USD – 21.00 USD

# Analysts2

Ownership

Shares Out.13.38M

Float11.29M

Insiders6.40%

Institutions93.32%

Short Interest

Short Ratio4.2d

Short % Float3.02%

Short % Out.2.30%

Shares Short307.57K

Short (prev mo.)416.97K

Technical

SMA 5016.91 (+28.8%)

SMA 20013.32 (+63.5%)

Beta0.19

S&P 52W Chg18.16%

Avg Vol (30d)104.46K

Avg Vol (10d)116.94K

Technical Indicators

RSI (14)68.5

MACD1.5695

MACD Signal1.4752

MACD Hist.+0.0943

BB Upper24.52 USD

BB Middle19.28 USD

BB Lower14.03 USD

BB Width54.43%

ATR (14)1.155 USD

Vol Ratio (20d)2.93x